Yusen Dai

机构：Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Luye Pharma (China)

发表论文 12 篇 · 总被引 162 次 · h-index 5

代表论文

• Maltol Promotes Mitophagy and Inhibits Oxidative Stress via the Nrf2/PINK1/Parkin Pathway after Spinal Cord Injury (2022 · Oxidative Medicine and Cellular Longevity · 被引 53)
• Inhibition of Autophagy by Estradiol Promotes Locomotor Recovery after Spinal Cord Injury in Rats (2016 · Neuroscience Bulletin · 被引 53)
• Paeoniflorin inhibits nucleus pulposus cell apoptosis by regulating the expression of Bcl-2 family proteins and caspase-9 in a rabbit model of intervertebral disc degeneration (2015 · Experimental and Therapeutic Medicine · 被引 27)
• Improving the treatment of Parkinson's disease: Structure-based development of novel 5-HT2A receptor antagonists/inverse agonists (2022 · European Journal of Medicinal Chemistry · 被引 13)
• Rational Design of the First Dual Agonist at Trace Amine-Associated Receptor 1 and 5-HT 2C Receptors Based on Binding Pocket Similarity for the Treatment of Schizophrenia and Alzheimer’s Disease-Related Psychosis (2025 · Journal of Medicinal Chemistry · 被引 6)
• Percutaneous transforaminal endoscopic discectomy for lumbar disc herniation: an efficacy analysis (2024 · American Journal of Translational Research · 被引 5)